In a major win for  Boston-based Dana-Farber Cancer Institute, a federal court ruled that one of its researchers should be listed as an inventor on six patents that are believed to be worth billions of dollars.

In a victory for Merck, the U.S. Supreme Court threw out a lower court decision May 20 that had revived a class-action lawsuit accusing the drugmaker of failing to warn patients of risks associated with its osteoporosis drug Fosamax, according to Reuters.

Here are 10 hospitals and health systems that posted job listings seeking pharmacy leaders in the last week.

Hyannis, Mass.-based Cape Cod Healthcare will close two retail pharmacies and reduce hours at a third by June 1, according to the Cape Cod Times.

CMS issued a final rule May 16 that makes several changes to Medicare Advantage and Part D. The final rule is a scaled-back version of the proposed rule.

Nestlé, a Swiss consumer goods giant, has entered exclusive talks to sell its skin health business to a consortium led by private equity firm EQT Partners for $10.1 billion, according to The Wall Street Journal.

Five more U.S. states filed lawsuits accusing Purdue Pharma of contributing to the nationwide opioid epidemic by illegally marketing and selling OxyContin, according to Reuters.

The Metropolitan Museum of Art will stop accepting donations from the family that owns OxyContin maker Purdue Pharma, according to The New York Times.

CVS Health is launching a new program that will require third-party testing on all vitamins and supplements sold at its stores to ensure accuracy of the dietary ingredients and guard against contamination.

Gilead Science CEO Daniel O'Day will testify May 16 on Capitol Hill  in front of a House committee over the pricing for its HIV prevention pill, according to STAT.

In an effort to lower prescription drug costs in the U.S., CMS issued a new guidance May 15 to limit the prevalence of spread pricing in Medicaid managed care plans.

Pennsylvania Attorney General Josh Shapiro accused Purdue Pharma of fueling the opioid epidemic in the state in a lawsuit filed May 14, according to The Hill.

ProvideGx, a subsidiary of Premier, will collaborate with Fresenius Kabi to help mitigate national shortages of five generic injectable medications.

Civica Rx, the nonprofit generic drugmaker formed by a group of health systems, will begin by distributing two essential antibiotics, the company announced May 15.

Johnson & Johnson and Teva Pharmaceuticals lost a last-minute bid to escape an opioid lawsuit brought against them by the state of Oklahoma, according to Reuters.

Kentucky is suing three insulin makers — Eli Lilly, Sanofi and Novo Nordisk —  over alleged price-gouging, according to The Hill. The state is the latest to sue insulin manufacturers over the pricing of the product.

AbbVie and Boehringer Ingelheim have resolved their patent dispute over a biosimilar to Humira, the companies announced May 14.

Medications purchased at discounted rates under the federal 340B program hit a record $24.3 billion in 2018, up 26 percent from 2017, according to Health Resources and Service Administration data cited by pharmaceutical website Drug Channels.

A San Francisco jury ordered Bayer to pay more than $2 billion to a couple who claimed the company's weedkiller caused their cancer, according to CNBC.

The $300 billion of Chinese imports potentially subject to U.S. tariffs won't include pharmaceuticals and select medical products, according to Reuters.